JUL 29, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Ciclopirox Olamine (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling change to an existing topical antifungal; does not report clinical trial outcomes or comparative efficacy data.
Reported
Approval date2026-07-29
Product strength0.77%